Omega Fund Management as of March 31, 2025
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 13 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kestra Med Technologies Common Stock (KMTS) | 26.4 | $45M | 1.8M | 24.92 | |
| Bicara Therapeutics Common Stock (BCAX) | 17.0 | $29M | 2.2M | 13.03 | |
| Beta Bionics Common Stock (BBNX) | 14.4 | $24M | 2.0M | 12.24 | |
| Nuvation Bio Common Stock Class A (NUVB) | 13.6 | $23M | 13M | 1.76 | |
| Replimune Group Common Stock (REPL) | 11.4 | $19M | 2.0M | 9.75 | |
| Upstream Bio Common Stock (UPB) | 7.4 | $13M | 2.0M | 6.12 | |
| Lexeo Therapeutics Common Stock (LXEO) | 2.4 | $4.1M | 1.2M | 3.47 | |
| Alumis Common Stock (ALMS) | 2.4 | $4.0M | 653k | 6.14 | |
| Ikena Oncology Common Stock (IKNA) | 1.7 | $2.9M | 2.2M | 1.28 | |
| enGene Holdings Common Stock (ENGN) | 1.4 | $2.4M | 526k | 4.48 | |
| Immunic Common Stock (IMUX) | 1.2 | $1.9M | 1.8M | 1.09 | |
| Sana Biotechnology Common Stock (SANA) | 0.8 | $1.4M | 844k | 1.68 | |
| enGene Holdings Warrant (ENGNW) | 0.1 | $193k | 322k | 0.60 |
